Active ingredientDopexamine DihydrochlorideCat. No. P-D171-001CAS 86484-91-5Family · Pharmaceutical analytical standards
Dopexamine
A synthetic dopamine analogue that stimulates beta-2 adrenergic and dopamine receptors, developed in the 1980s: it is given intravenously in hospital to support the heart in heart failure, including after cardiac surgery. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?It lasts very briefly in the blood: its half-life is just 6-7 minutes in healthy people and about 11 minutes in patients with heart failure.
Go to the active ingredient →Active ingredientDopexamine DihydrochlorideCat. No. P-D171-001CAS 86484-91-5
Pharmacopoeial impurityDopexamine EP Impurity BCat. No. P-D171-002
Pharmacopoeial impurityDopexamine EP Impurity FCat. No. P-D171-003No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceDopexamine dihydrochloride CRSEDQM code Y0000612Family DopexamineImpurityDopexamine impurity B CRSEDQM code Y0000613Family DopexamineImpurityDopexamine impurity F CRSEDQM code Y0000614Family DopexamineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.